Rashid Giniatullin Selected Research

diadenosine- 5',5'''- P(1),P(4)- (beta,beta'- methylene)tetraphosphonate

1/2019

Diadenosine-Polyphosphate Analogue AppCH2ppA Suppresses Seizures by Enhancing Adenosine Signaling in the Cortex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rashid Giniatullin Research Topics

Disease

31	Migraine Disorders (Migraine) 04/2022 - 06/2006
31	Pain (Aches) 04/2022 - 01/2003
9	Headache (Headaches) 01/2022 - 11/2013
5	Chronic Pain 03/2021 - 02/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 07/2003
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 06/2011
3	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 02/2014
3	Hyperhomocysteinemia 01/2022 - 01/2015
3	Inflammation (Inflammations) 01/2022 - 06/2011
3	Hyperalgesia 01/2022 - 01/2016
3	Migraine with Aura (Familial Hemiplegic Migraine) 01/2021 - 08/2010
3	Epilepsy (Aura) 01/2019 - 01/2017
2	Neuroinflammatory Diseases 01/2020 - 01/2019
2	Seizures (Absence Seizure) 01/2019 - 01/2017
1	Photophobia (Light Sensitivity) 01/2022
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022
1	Hypoxia (Hypoxemia) 10/2019
1	Drug Resistant Epilepsy 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Migraine without Aura (Common Migraine) 01/2018
1	Disease Progression 10/2017
1	Nervous System Diseases (Neurological Disorders) 02/2017
1	Atrophy 01/2017
1	Aphasia (Dysphasia) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Neoplasms (Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

21	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2003
7	Calcitonin Gene-Related PeptideIBA 01/2021 - 06/2006
6	Analgesics (Analgesic Drugs)IBA 04/2022 - 06/2006
6	HomocysteineIBA 01/2022 - 04/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
5	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 03/2006
5	Purinergic P2X3 ReceptorsIBA 01/2011 - 06/2006
4	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 11/2013
4	Capsaicin (Zostrix)FDA Link 03/2021 - 03/2006
3	EnzymesIBA 04/2022 - 01/2018
3	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2022 - 01/2018
3	EndocannabinoidsIBA 04/2022 - 01/2018
3	Monoacylglycerol LipasesIBA 04/2022 - 01/2018
3	Ion Channels (Ion Channel)IBA 04/2022 - 05/2020
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2016
3	NeuropeptidesIBA 02/2017 - 06/2006
3	Nerve Growth Factor (NGF)IBA 02/2008 - 03/2006
2	N-Methylaspartate (NMDA)IBA 01/2022 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2017
2	CollagenIBA 01/2022 - 01/2017
2	CannabinoidsIBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2014
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2016
2	PlasticsIBA 01/2020 - 03/2006
2	diadenosine tetraphosphateIBA 01/2019 - 01/2016
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2018
2	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2017 - 01/2017
2	Carbachol (Carbastat)FDA Link 02/2017 - 01/2017
2	Cholinergic Agents (Cholinergics)IBA 02/2017 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 02/2014
2	Amino Acids FDA Link 01/2016 - 01/2015
1	Amyloid beta-PeptidesIBA 06/2022
1	anandamide (arachidonylethanolamide)IBA 04/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2022
1	MagnesiumIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Tryptamines (Triptans)IBA 01/2022
1	CytokinesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2022
1	LigandsIBA 01/2022
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	HydrolasesIBA 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	incobotulinumtoxinA FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	sodium bisulfide (NaHS)IBA 01/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	GasotransmittersIBA 01/2020
1	CalciumIBA 01/2019
1	diadenosine- 5',5'''- P(1),P(4)- (beta,beta'- methylene)tetraphosphonateIBA 01/2019
1	trans-sodium crocetinate (crocetin)IBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	PolyphosphatesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 12/2017
1	AntioxidantsIBA 10/2017
1	Nicotine FDA Link 02/2017
1	NitrogenIBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Neostigmine (Neostigmine Bromide)IBA 01/2017
1	Cholinergic ReceptorsIBA 01/2017
1	Tubocurarine (Tubocurarine Chloride)FDA Link 01/2017

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2017
4	Analgesia 04/2022 - 01/2011
1	Cell Transplantation 01/2022
1	Injections 01/2021
1	Electroacupuncture 05/2020
1	Induced Hyperthermia (Thermotherapy) 10/2019